1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Chronic Cough Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Chronic Cough Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Chronic Cough Market Regional Analysis
6.2 Asia Pacific Chronic Cough Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Chronic Cough Market Forecast Analysis
7. Asia Pacific Chronic Cough Market Analysis – by Drug Class
7.1 Antihistamines
- 7.1.1 Overview
- 7.1.2 Antihistamines: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Corticosteroids
- 7.2.1 Overview
- 7.2.2 Corticosteroids: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Decongestants
- 7.3.1 Overview
- 7.3.2 Decongestants: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Combination Drug
- 7.4.1 Overview
- 7.4.2 Combination Drug: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Antibiotics
- 7.5.1 Overview
- 7.5.2 Antibiotics: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Acid Blockers
- 7.6.1 Overview
- 7.6.2 Acid Blockers: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Other Drug Class
- 7.7.1 Overview
- 7.7.2 Other Drug Class: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Chronic Cough Market Analysis – by Route of Administration
8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Injections
- 8.2.1 Overview
- 8.2.2 Injections: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Nasal
- 8.3.1 Overview
- 8.3.2 Nasal: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Other Route of Administration
- 8.4.1 Overview
- 8.4.2 Other Route of Administration: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Chronic Cough Market Analysis – by Distribution Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Online Pharmacy
- 9.2.1 Overview
- 9.2.2 Online Pharmacy: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: Asia Pacific Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Asia Pacific Chronic Cough Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific
- 10.2.1 Asia Pacific Chronic Cough Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Asia Pacific Chronic Cough Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 China:
Asia Pacific Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.1.2 China: Asia Pacific Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.1.3 China: Asia Pacific Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.2 India:
Asia Pacific Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.2.2 India: Asia Pacific Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.2.3 India: Asia Pacific Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.3 Japan:
Asia Pacific Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.3.2 Japan: Asia Pacific Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.3.3 Japan: Asia Pacific Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.4 Australia:
Asia Pacific Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.4.2 Australia: Asia Pacific Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.4.3 Australia: Asia Pacific Chronic Cough Market Breakdown, by Distribution Channel
- 10.2.1.5 Rest of Asia-Pacific :
Asia Pacific Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Chronic Cough Market Breakdown, by Drug Class
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Chronic Cough Market Breakdown, by Route of Administration
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Chronic Cough Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Novartis AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Teva Pharmaceutical Industries Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bayer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mylan N.V.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Amneal Pharmaceuticals, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Cipla Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Reckitt Benckiser Group plc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Aurobindo Pharma Ltd.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations